Curasight A/S announces ownership restructuring
Curasight A/S has announced a significant change in its ownership structure following an internal restructuring. Curacap Holding ApS now holds 27.68% of the company's shares and voting rights.
Copenhagen, Denmark – Curasight A/S announced on Tuesday, September 14, 2026, a significant shift in its ownership structure. The company received notification regarding a restructuring of an existing major shareholding, leading to a change in the controlling stake.
As a result of this internal restructuring, Curacap Holding ApS now holds 27.68% of the shares and voting rights in Curasight A/S. This move consolidates a substantial portion of the company's ownership under a single entity.
The announcement complies with the major shareholding notification rules of the Spotlight Stock Market. The company's co-founder and executive management have been actively involved in its development.
Curasight A/S is focused on the development of diagnostic and therapeutic solutions. Such adjustments in ownership can indicate strategic shifts or a consolidation of control within the company. Further details regarding the company's strategic direction are anticipated.